Skip to Content

I G 225 (Gemfibrozil 600 mg)

Pill imprint I G 225 has been identified as Gemfibrozil 600 mg.

Gemfibrozil is used in the treatment of high cholesterol; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Gemfibrozil 600 mg is not a controlled substance under the Controlled Substance Act (CSA).

Gemfibrozil 600 mg I G 225
Gemfibrozil 600 mg I G 225
Gemfibrozil 600 mg I G 225 Front
Gemfibrozil 600 mg I G 225 Back
Gemfibrozil 600 mg I G 225
I G 225
600 mg
19.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Major Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
calcium stearate
silicon dioxide colloidal
croscarmellose sodium
microcrystalline cellulose
methylcellulose (100 mPa.s)
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
31722-0225 Camber Pharmaceuticals Inc.
68084-0473 Amerisource Health Services
24658-0130 Blu Pharmaceuticals LLC
00143-9130 West-Ward Pharmaceuticals
67544-1111 Prepak Systems Inc (repackager)
53002-1068 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.